Suppr超能文献

瑞士:卫生系统评估

Switzerland: Health System Review.

作者信息

De Pietro Carlo, Camenzind Paul, Sturny Isabelle, Crivelli Luca, Edwards-Garavoglia Suzanne, Spranger Anne, Wittenbecher Friedrich, Quentin Wilm

机构信息

Department of Business Economics, Health and Social Care at the University of Applied Sciences and Arts of Southern Switzerland.

Swiss Health Observatory (Obsan) in Neuchatel.

出版信息

Health Syst Transit. 2015;17(4):1-288, xix.

Abstract

This analysis of the Swiss health system reviews recent developments in organization and governance, health financing, health care provision, health reforms and health system performance. The Swiss health system is highly complex, combining aspects of managed competition and corporatism (the integration of interest groups in the policy process) in a decentralized regulatory framework shaped by the influences of direct democracy. The health system performs very well with regard to a broad range of indicators. Life expectancy in Switzerland (82.8 years) is the highest in Europe after Iceland, and healthy life expectancy is several years above the European Union (EU) average. Coverage is ensured through mandatory health insurance (MHI), with subsidies for people on low incomes. The system offers a high degree of choice and direct access to all levels of care with virtually no waiting times, though managed care type insurance plans that include gatekeeping restrictions are becoming increasingly important. Public satisfaction with the system is high and quality is generally viewed to be good or very good. Reforms since the year 2000 have improved the MHI system, changed the financing of hospitals, strengthened regulations in the area of pharmaceuticals and the control of epidemics, and harmonized regulation of human resources across the country. In addition, there has been a slow (and not always linear) process towards more centralization of national health policy-making. Nevertheless, a number of challenges remain. The costs of the health care system are well above the EU average, in particular in absolute terms but also as a percentage of gross domestic product (GDP) (11.5%). MHI premiums have increased more quickly than incomes since 2003. By European standards, the share of out-of-pocket payments is exceptionally high at 26% of total health expenditure (compared to the EU average of 16%). Low and middle-income households contribute a greater share of their income to the financing of the health system than higher-income households. Flawed financial incentives exist at different levels of the health system, potentially distorting the allocation of resources to different providers. Furthermore, the system remains highly fragmented as regards both organization and planning as well as health care provision.

摘要

对瑞士医疗体系的这一分析审视了其在组织与治理、卫生筹资、医疗服务提供、医疗改革及医疗体系绩效方面的近期发展情况。瑞士医疗体系高度复杂,在由直接民主影响形成的分散监管框架内,融合了管理竞争和社团主义(利益集团在政策过程中的整合)的诸多方面。就一系列广泛指标而言,该医疗体系表现出色。瑞士的预期寿命(82.8岁)在欧洲仅次于冰岛,位居第二,健康预期寿命比欧盟平均水平高出数年。通过强制医疗保险(MHI)确保了医保覆盖范围,并为低收入人群提供补贴。该体系提供了高度的选择自由,可直接获得各级医疗服务,几乎无需等待时间,不过包括守门人限制的管理式医疗类保险计划正变得越来越重要。公众对该体系满意度较高,普遍认为医疗质量良好或非常好。自2000年以来的改革改进了MHI体系,改变了医院的筹资方式,加强了药品领域和疫情防控方面的监管,并在全国范围内统一了人力资源监管。此外,国家卫生政策制定出现了向更集权化发展的缓慢(且并非总是呈线性)进程。然而,仍存在一些挑战。医疗体系成本远高于欧盟平均水平,尤其是从绝对值来看,而且占国内生产总值(GDP)的比例也较高(11.5%)。自2003年以来,MHI保费增长速度超过了收入增长速度。按照欧洲标准,自付费用在卫生总支出中所占份额异常高,达到26%(相比之下欧盟平均水平为16%)。低收入和中等收入家庭在卫生体系筹资中所占收入份额高于高收入家庭。医疗体系不同层面存在有缺陷的财务激励措施,可能会扭曲资源向不同医疗服务提供者的分配。此外,该体系在组织与规划以及医疗服务提供方面仍高度分散。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验